The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2017
Filed:
Mar. 21, 2016
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
George Heavner, Malvern, PA (US);
David M. Knight, Berwyn, PA (US);
Jill Giles-Komar, Downingtown, PA (US);
Bernard Scallon, Wayne, PA (US);
David Shealy, Downingtown, PA (US);
Assignee:
Janssen Biotech, Inc., Horsham, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 9/19 (2006.01); A61K 39/395 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/27 (2006.01); A61K 45/06 (2006.01); C07K 16/42 (2006.01); G01N 33/566 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/241 (2013.01); A61K 9/19 (2013.01); A61K 38/1816 (2013.01); A61K 38/19 (2013.01); A61K 38/27 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 16/42 (2013.01); C07K 16/4241 (2013.01); G01N 33/566 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); Y10S 514/825 (2013.01); Y10S 514/826 (2013.01);
Abstract
The present invention relates to anti-TNF antibodies comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein or fragment thereof, as well as nucleic acids encoding such anti-TNF antibodies, complementary nucleic acids, vectors, host cells, production methods and therapeutic methods.